Role of HDAC6 and Its Selective Inhibitors in Gastrointestinal Cancer
Worldwide, cancer is the second leading cause of mortality after cardiovascular diseases. Among the numerous malignant tumors in human, digestive system cancers are the primary cause of morbidity and mortality. Acetylation and deacetylation are crucially involved in cancer occurrence and development...
Enregistré dans:
Auteurs principaux: | Bingyi Zhou, Deliang Liu, Yuyong Tan |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4bba92dba64941db88bd778c548d3f1b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Metabolism, HDACs, and HDAC Inhibitors: A Systems Biology Perspective
par: Jacob King, et autres
Publié: (2021) -
Epigenetic Repression of Chloride Channel Accessory 2 Transcription in Cardiac Fibroblast: Implication in Cardiac Fibrosis
par: Tinghui Shao, et autres
Publié: (2021) -
Clinical use and applications of histone deacetylase inhibitors in multiple myeloma
par: Tandon N, et autres
Publié: (2016) -
Molecular cloning and subcellular localization of six HDACs and their roles in response to salt and drought stress in kenaf (Hibiscus cannabinus L.)
par: Wei,Fan, et autres
Publié: (2019) -
The Potential Role of Epigenetic Drugs in the Treatment of Anxiety Disorders
par: Peedicayil J
Publié: (2020)